[1]
Matsui, K. et al. 2017. Topical Application of Josamycin Inhibits Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice. Journal of Pharmacy & Pharmaceutical Sciences. 20, (Mar. 2017), 38–47. DOI:https://doi.org/10.18433/J3GW3D.